Phase II evaluation of chlorozotocin in patients with renal cell carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000187:drug effects; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013311:Streptozocin / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity
D013311:Streptozocin